Stock Analysis on Net

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)

Analysis of Debt

Microsoft Excel

Total Debt (Carrying Amount)

Regeneron Pharmaceuticals Inc., balance sheet: debt

US$ in thousands

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Finance lease liabilities, current portion 719,700
Long-term debt 1,982,900 1,981,400 1,980,000 1,978,500
Finance lease liabilities, excluding current portion 720,000 720,000 717,200 713,900
Total long-term debt and finance lease liabilities (carrying amount) 2,702,900 2,701,400 2,699,700 2,695,700 713,900

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Debt item Description The company
Total long-term debt and finance lease liabilities (carrying amount) Sum of the carrying values as of the balance sheet date of all debt plus capital lease obligations. Regeneron Pharmaceuticals Inc. total debt increased from 2021 to 2022 and from 2022 to 2023.

Total Debt (Fair Value)

Microsoft Excel
Dec 31, 2023
Selected Financial Data (US$ in thousands)
Long-term debt 1,528,000
Finance lease liabilities 720,000
Total long-term debt and finance lease liabilities (fair value) 2,248,000
Financial Ratio
Debt, fair value to carrying amount ratio 0.83

Based on: 10-K (reporting date: 2023-12-31).


Weighted-average Interest Rate on Debt

Weighted-average interest rate on debt and finance lease liabilities: 2.92%

Interest rate Debt amount1 Interest rate × Debt amount Weighted-average interest rate2
1.75% 1,242,200 21,739
2.80% 740,700 20,740
5.08% 720,000 36,576
Total 2,702,900 79,054
2.92%

Based on: 10-K (reporting date: 2023-12-31).

1 US$ in thousands

2 Weighted-average interest rate = 100 × 79,054 ÷ 2,702,900 = 2.92%